Phenotypic characteristics of Branhamella catarrhalis strains - PubMed (original) (raw)

Phenotypic characteristics of Branhamella catarrhalis strains

J L Soto-Hernandez et al. J Clin Microbiol. 1989 May.

Abstract

Isolates of Branhamella catarrhalis from 13 patients with pneumonia, 6 patients with tracheobronchitis, and 8 patients who were colonized with the organism were studied with respect to susceptibility to the bactericidal action of normal human serum (NHS), glass slide hemagglutination (HA) of group O human erythrocytes, beta-lactamase production, and susceptibility to selected antimicrobial agents and laboratory drugs. A total of 18 of 27 isolates were serum resistant, 22 of 27 produced HA, and 21 of 27 were beta-lactamase positive. Statistically significant correlations were found between susceptibility to NHS and susceptibility to trypsin (r = +0.47; P = 0.01) and between susceptibility to NHS and HA (r = -0.48; P = 0.009). Significant correlations were also observed among several pairs of antimicrobial drugs. Analysis of variance showed that mean ampicillin MICs correlated with isolate group (r = -0.49; P = 0.03) in that the pneumonia isolates had higher MICs. Some phenotypic characteristics appeared to be independent of each other. These data suggest that important differences exist among clinically significant B. catarrhalis strains and that these differences may be due to differences in the cell wall envelope of the organism.

PubMed Disclaimer

Similar articles

• Molecular characterization of the beta-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 U.S. medical centers during 1994-1995 and 1997-1998.
  Richter SS, Winokur PL, Brueggemann AB, Huynh HK, Rhomberg PR, Wingert EM, Doern GV. Richter SS, et al. Antimicrob Agents Chemother. 2000 Feb;44(2):444-6. doi: 10.1128/AAC.44.2.444-446.2000. Antimicrob Agents Chemother. 2000. PMID: 10639381 Free PMC article.
• Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States.
  Jorgensen JH, Doern GV, Maher LA, Howell AW, Redding JS. Jorgensen JH, et al. Antimicrob Agents Chemother. 1990 Nov;34(11):2075-80. doi: 10.1128/AAC.34.11.2075. Antimicrob Agents Chemother. 1990. PMID: 2127342 Free PMC article.
• Moraxella (Branhamella) catarrhalis.
  Verghese A, Berk SL. Verghese A, et al. Infect Dis Clin North Am. 1991 Sep;5(3):523-38. Infect Dis Clin North Am. 1991. PMID: 1955698 Review.
• Pneumonia due to Moraxella (Branhamella) catarrhalis.
  Wright PW, Wallace RJ Jr. Wright PW, et al. Semin Respir Infect. 1989 Mar;4(1):40-6. Semin Respir Infect. 1989. PMID: 2496450 Review.

Cited by

• Epidemiological typing of Moraxella catarrhalis by pulsed field gel electrophoresis.
  Davison SM, Low DE, Cruz RH, Beaulieu D, Scriver SR. Davison SM, et al. Can J Infect Dis. 1995 May;6(3):141-4. doi: 10.1155/1995/187049. Can J Infect Dis. 1995. PMID: 22514386 Free PMC article.
• Identification of a bacteriocin and its cognate immunity factor expressed by Moraxella catarrhalis.
  Attia AS, Sedillo JL, Hoopman TC, Liu W, Liu L, Brautigam CA, Hansen EJ. Attia AS, et al. BMC Microbiol. 2009 Sep 25;9:207. doi: 10.1186/1471-2180-9-207. BMC Microbiol. 2009. PMID: 19781080 Free PMC article.
• Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade.
  Attia AS, Ram S, Rice PA, Hansen EJ. Attia AS, et al. Infect Immun. 2006 Mar;74(3):1597-611. doi: 10.1128/IAI.74.3.1597-1611.2006. Infect Immun. 2006. PMID: 16495531 Free PMC article.
• The UspA2 protein of Moraxella catarrhalis is directly involved in the expression of serum resistance.
  Attia AS, Lafontaine ER, Latimer JL, Aebi C, Syrogiannopoulos GA, Hansen EJ. Attia AS, et al. Infect Immun. 2005 Apr;73(4):2400-10. doi: 10.1128/IAI.73.4.2400-2410.2005. Infect Immun. 2005. PMID: 15784586 Free PMC article.
• Moraxella catarrhalis: from emerging to established pathogen.
  Verduin CM, Hol C, Fleer A, van Dijk H, van Belkum A. Verduin CM, et al. Clin Microbiol Rev. 2002 Jan;15(1):125-44. doi: 10.1128/CMR.15.1.125-144.2002. Clin Microbiol Rev. 2002. PMID: 11781271 Free PMC article. Review.

References

1. 1. J Infect Dis. 1973 Sep;128(3):321-30 - PubMed
2. 1. J Infect Dis. 1988 May;157(5):996-1001 - PubMed
3. 1. Infect Immun. 1978 Jan;19(1):332-40 - PubMed
4. 1. J Clin Microbiol. 1980 Feb;11(2):193-5 - PubMed
5. 1. Infect Immun. 1981 Jul;33(1):212-22 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information